Duke Hematology Case Conference (WebEx Only)

TUESDAY, February 15, 2022 – 8:00AM TO 9:00AM

Heme Vignette:

“Prolonged PT in a Patient with SCD: A Curious Finding”

Regina Crawford, MD

Associate Professor

Department of Medicine

Duke University Medical Center

Fellow Talk:

 "GI Bleed Management in Patients Declining Blood Transfusion"

Cameron Oswalt

Heme-Onc Fellow (1st Year)

Department of Medicine

Duke University Medical Center

CME Offered
The following speakers and planners for this conference have no relevant financial relationships with ineligible companies to disclose:

 Regina Crawford, MD; Cameron Oswalt, MD; Marilyn Telen, MD; Kim Hodulik, PharmD; Karen Baker, RN, BSN

The following planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

Tom Ortel, MD, PhD; Gow Arepally, MD; Ammon Fager, MD, PhD

JA Accreditation Statement:

In support of improving patient care, the Duke University Health System Department of Clinical Education & Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.

Credit Designation: Duke University Health System Department of Clinical Education and Professional Development designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Unapproved Use Disclosure: Duke University Health System Department of Clinical Education & Professional Development requires faculty (speakers) to disclose to the attendees: 1) When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and 2) Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty at this symposium may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing
information.